Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Xiangyun Zong"'
Autor:
Weiwei Zong, Eric Carver, Simeng Zhu, Eric Schaff, Daniel Chapman, Joon Lee, Hassan Bagher-Ebadian, Benjamin Movsas, Winston Wen, Tarik Alafif, Xiangyun Zong
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Automatic diagnosis of malignant prostate cancer patients from mpMRI has been studied heavily in the past years. Model interpretation and domain drift have been the main road blocks for clinical utilization. As an extension from our previous
Externí odkaz:
https://doaj.org/article/f436834c607d4632a41009330e5b1025
Publikováno v:
Breast, Vol 64, Iss , Pp 143-150 (2022)
Background: As a special reproductive hormone and ovarian reserve indicator, the role of anti-Müllerian hormone (AMH) in premenopausal women with breast cancer deserves further study. Methods: We conducted an in-depth analysis of the data from the E
Externí odkaz:
https://doaj.org/article/f1ca067d743b4a398c48bf8293048343
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-11 (2021)
Abstract Chemotherapy-induced ovarian dysfunction is a serious adverse effect in premenopausal patients with cancer. Gonadotrophin-releasing hormone analogs (GnRHa) protect ovarian function, but its molecular mechanisms have not yet been determined.
Externí odkaz:
https://doaj.org/article/5f42003b8ee944e89ba1d69d78f71cb5
Autor:
Lisi Ma, Xiangyun Zong
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Cellular metabolic reprogramming is now recognized as a hallmark of tumors. Altered tumor metabolism determines the malignant biological behaviors and phenotypes of cancer. More recently, studies have begun to reveal that cancer cells generally exhib
Externí odkaz:
https://doaj.org/article/4726548070cc4d77aab166a9a2aa5231
Publikováno v:
Endocrine-Related Cancer; Oct2023, Vol. 30 Issue 10, p82-96, 15p
Autor:
Xiangyun Zong, Yang Yu, Hongjian Yang, Wenhu Chen, Xiaowen Ding, Sixuan Liu, Xiaolin Li, Xuan Chen, Chuner Jiang, Xianghou Xia, Run Huang, Meizhen Zhu, Jiejie Hu, Chenlu Liang
Publikováno v:
JAMA Oncol
IMPORTANCE: Studies of the use of gonadotropin-releasing hormone analogs (GnRHa) to protect ovarian function have shown mixed results. OBJECTIVE: To determine whether administering GnRHa during chemotherapy in premenopausal women with breast cancer c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c5d311569e6e4b2f045ead0fbe37575
https://pubmed.ncbi.nlm.nih.gov/35420636
https://pubmed.ncbi.nlm.nih.gov/35420636
Publikováno v:
Cancer Management and Research. 12:8171-8181
Purpose The predictive value of anti-Mullerian hormone (AMH) for ovarian dysfunction postchemotherapy is controversial. This study aimed to evaluate the value of serum AMH levels clinically and theoretically. Patients animals and methods We detected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4831429795fcd7c7b47bde4e9882f5b
https://doi.org/10.2147/cmar.s269249
https://doi.org/10.2147/cmar.s269249
Autor:
XIANGYUN ZONG, Yang Yu
Publikováno v:
JAMA Oncology. 8:944
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975c86a232c5f47355abbaae43c8aa69
https://doi.org/10.1001/jamaoncol.2022.0491
https://doi.org/10.1001/jamaoncol.2022.0491
Publikováno v:
NPJ Breast Cancer
npj Breast Cancer, Vol 7, Iss 1, Pp 1-11 (2021)
npj Breast Cancer, Vol 7, Iss 1, Pp 1-11 (2021)
Chemotherapy-induced ovarian dysfunction is a serious adverse effect in premenopausal patients with cancer. Gonadotrophin-releasing hormone analogs (GnRHa) protect ovarian function, but its molecular mechanisms have not yet been determined. In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60afe9f18a94d0f4e3fdb4ad620c6a1b
https://pubmed.ncbi.nlm.nih.gov/34620881
https://pubmed.ncbi.nlm.nih.gov/34620881
Background The predicting value of AMH for ovarian dysfunction after chemotherapy is controversial. This study is designed to evaluate the value of serum AMH clinically and theoretically. Methods We detected the serum estradiol, FSH and AMH in 144 pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f63ace7bb8e7e62b6e58872c3318d04
https://doi.org/10.21203/rs.3.rs-16366/v1
https://doi.org/10.21203/rs.3.rs-16366/v1
